When: RSI bullish divergence at oversold

Then: Upgrade thesis evaluation

When: Forward EPS reaffirmation at $6.00+ with Nutrition stabilization

Then: Upgrade thesis evaluation

SELL - Trim exposure immediately at spot, not into a rally that may never come; set wider stops around 94.50 (1.5 ATR) rather than holding through Q3 binary event with tight stop at 96.98

• Abbott's balance sheet transformation is real: net debt increased from 4.4 billion to 27.2 billion in a single quarter, making pre- and post-acquisition Abbott 'not the same security'
• Q2 interest expense of 174 million is the new run rate that will persist for years
• 23.6 billion in new intangibles with 10-15 year amortization tail will compress GAAP earnings across the forward curve
• The aggressive plan requires stock to rally 5-6 percent from current levels to 103-104 where multiple moving averages create resistance: 10 EMA at 99.78, 200 SMA at 102.89, 50 SMA at 106.65
• Aggressive stop at 96.98 is only 1.18 dollars away (half an ATR) and sits on the Bollinger lower band directly in front of a binary catalyst
• If stock chops sideways between 96-100 for three weeks and gaps down into Q3 print, position is sold into weakness rather than strength
• ABT is not receiving defensive rotation benefits: stock is 15 percent off August high, has a death cross, and trades 8 percent below 50-day moving average
• The market is treating ABT as a balance sheet event, not a defensive beneficiary; the August rotation window has closed
• Asymmetry argument: 5 percent better exit worth ~50 cents per share versus 10-15 percent drawdown to 88 worth $10-15 per share — not subtle asymmetry
• Dividend at 2.5 percent does not justify holding through a broken chart with 19.8 billion integration story, elevated interest expense, and death cross
• Conservative plan: reduce exposure now, size remaining exposure so Q3 miss costs only 50 basis points to portfolio not 200 basis points, set stops at 94.50 (1.5 ATR below spot)

→ vs aggressive: Execution plan requires stock to rally 5-6 percent into resistance without any momentum shift (RSI below 50, no MACD crossover, no day of accumulation since January distribution) — betting a broken chart will mount relief rally

→ vs aggressive: Stop at 96.98 is effectively the Bollinger lower band sitting in front of a binary catalyst; one bad session on Q3 guidance and stop is gone before reaction time

→ vs aggressive: Recommending plan that risks being late by holding through binary event with inadequate stop protection despite framing about being early to preserve capital

→ vs neutral: Defensive rotation thesis dangerously misapplied; if ABT were receiving defensive benefits, stock would not be 15 percent off August high with death cross and trading 8 percent below 50-day moving average

→ vs neutral: The market is treating ABT as a balance sheet event, not a defensive beneficiary; the August rotation window has closed and neutral analyst is looking backward

SELL - Execute three tranche trim: sell ~1/3 at spot (97-99), ~1/3 on bounce to 100-102, hold 1/3 tail with 94.50 stop for Q3 print

• Directional call is SELL, conviction high; agrees with both aggressive and conservative analysts on direction
• Aggressive analyst's 103-104 target requires bulls to push through three layers of overhead supply (10 EMA at 99.78, 200 SMA at 102.89, 50 SMA at 106.65) with limited time before Q3; estimates 25-30% probability
• Base case is sideways chop in 96-101 range while 10 EMA catches down to price, not the relief rally scenario
• Conservative analyst is correct that stop at 96.98 (Bollinger lower band) is a stop magnet; widened stop to 94.50 (1.5 ATR) needed
• Technical conditions for 1-2 day oversold bounce to 99-100 are decent: RSI bounced from 25.69 to 36.25, MACD histogram no longer accelerating downside, Bollinger lower band at 96.98 (0.48 ATR below spot)
• 10-year at 2002 highs and soft landing base case is textbook environment for ABT defensive bid eventually; defensive rotation thesis is backward-looking but valid post-Q3
• Three tranche framework: (1) Tranche 1: Sell ~1/3 at 97-99, (2) Tranche 2: Sell ~1/3 on relief bounce to 100-102 zone (200 SMA/10 EMA convergence), (3) Tranche 3: Hold final 1/3 with 94.50 stop through Q3 print, position sized for max 30-50 bps portfolio impact if stopped out
• Re-entry triggers: close above 103 on 1.5x average volume with MACD crossing above signal line, OR capitulation flush below 95 confirmed by RSI below 25 on daily close with 2x average volume
• ABT not yet benefiting from defensive rotation due to Q1 acquisition digestion; this changes after Q3 regardless of print outcome

→ vs aggressive: Aggressive plan is dependent on 5% relief rally (103-104) that may not materialize; if stock chops sideways into print at 97, plan never executes and you're on full exposure to binary event

→ vs conservative: Selling entire position at 98.16 captures worst possible print in a 2-3 dollar range likely to be tested on both sides; conflates 'trim now' with 'trim everything now' and gives up convexity for marginal execution quality

→ vs conservative: Claim that ABT not getting defensive rotation benefit is backward-looking; 10-year at 2002 highs and soft landing base case is textbook defensive environment for ABT post-Q3